Depakene is the trade name and generic name for sodium valproate extended-release tablets. Its serious side effects include abrupt discontinuation of the drug leading to hypoxia and life-threatening status epilepticus; other side effects include thrombocytopenia, anemia, and weight gain.
Sodium valproate extended-release tablets are broad-spectrum antiepileptic drugs that are used to treat epilepsy and mania. While using Sodium Valproate Extended-Release Tablets for the treatment of seizures, hypoxia and life-threatening status epilepticus may occur if the medication is stopped abruptly.
Adverse reactions that may occur while taking the drug include thrombocytopenia, anemia, weight gain, muscle fascicular tremor, extrapyramidal, drowsiness, memory impairment, dizziness, tinnitus, respiratory abnormalities, nausea and vomiting, gingival hyperplasia, abdominal pain and diarrhea, renal failure, alopecia, hyponatremia, and hepatic injury.
It is contraindicated in patients who are allergic to the components of the drug, in patients with acute and chronic hepatitis, in patients with hepatic porphyria, and in patients with urea cycle disorders. If you need to take sodium valproate extended-release tablets, please consult a professional doctor, follow the doctor’s instructions, reasonable use of medication.